Published August 27, 2026 · updated August 27, 2026 · medically reviewed by Dr. S. Shuwart, MD on August 27, 2026

Medically reviewed · August 27, 2026

Wegovy vs compounded semaglutide

The approved semaglutide product for weight management against compounded semaglutide: forms, dosing, the salt-form issue, evidence, regulation, and how each is priced through telehealth.

Wegovy

Novo Nordisk’s semaglutide product for chronic weight management, and for reducing cardiovascular risk in adults with established cardiovascular disease and overweight or obesity. It is supplied as a once-weekly pen (0.25 mg to 2.4 mg) and as a daily oral tablet. The STEP programme and the SELECT trial are its evidence base. On this site it is evidence grade A.

At our latest verification the database includes a telehealth pathway that sells Wegovy pens at a direct-to-patient cash price with a monthly plan fee on top, with the medication price and the fee recorded separately; see the semaglutide pricing page.

Compounded semaglutide

A preparation made by a 503A pharmacy or 503B outsourcing facility from semaglutide active ingredient, usually as a multi-dose vial, sometimes with vitamin B12 or other additives, and sometimes in sublingual or orally disintegrating forms. Not FDA-approved; not tested in STEP or SELECT. Injectable compounded semaglutide is grade C on this site; sublingual and ODT forms are grade D.

The salt-form issue

FDA has said that some compounders used semaglutide sodium or semaglutide acetate, salt forms that are not the active ingredient in the approved products. This matters for compounded semaglutide in a way it has not, so far, been documented for tirzepatide. A provider that states the pharmacy uses semaglutide base has answered the question; the base vs salt page explains what to ask.

Dosing and price structure

The pen delivers fixed doses on the labelled schedule. Compounded vials are drawn by volume, and compounded plans are usually priced in bands by total milligrams, rising as the dose rises; this site shows every plan at the 0.25 mg starting dose and at the 2.4 mg reference maintenance dose. Brand pathways separate the medication price from the plan fee. The brand vs compounded calculator compares them over twelve months.

Regulation

Compounding copies of an approved drug is permitted only in defined circumstances; the semaglutide legal status page describes the shortage’s end in 2025 and the bases on which providers continue.

Questions this page answers

Is there a generic Wegovy?
No. Compounded semaglutide is not a generic; it is a pharmacy preparation that is not FDA-approved.
What is the difference between the Wegovy pen and the Wegovy pill?
Both are approved manufacturer products containing semaglutide; the pen is a once-weekly injection and the pill is taken daily. Compounded 'oral' semaglutide is a different, unapproved product.

Sources

  1. Wegovy (semaglutide) prescribing information (label)
  2. FDA: Medications containing semaglutide marketed for type 2 diabetes or weight loss (regulator)
  3. Verified semaglutide plan prices (provider)

Related: /guides/ozempic-vs-compounded-semaglutide/ /guides/semaglutide-base-vs-salt/ /guides/compounded-semaglutide-legal-status/

Educational information, not medical advice. Decisions about GLP-1 medication belong with you and a licensed clinician who knows your history. Compounded medications are not FDA-approved. Report an error.